The Conclave intends to focus upon the issues that need urgent attention of the industry stakeholders. Further, it endeavors to bring the decision makers together so that the discussions result in meaningful actionable outcomes.
Specifically as objectives, the Conclave intends to create a forum for exchange of ideas and information for exploring the following themes.
Experience & Expertise - Indian pharma companies have a wide variety of experience in manufacturing as per global standards. Through intensive competition in the Indian market, Indian companies are experienced in the manufacturing of a variety of formulations that makes them efficient and competitive in their operations.
Low cost of manufacture - India is capable of manufacturing low cost generic alternatives due to a number of economic factors favoring the industry. Some of these include the competitive land rates, the cheap labour available, low resource costs like water, electricity etc., lower cost of production machinery. Importantly, the various drugs like, Intermediates, APIs and Formulation companies are seamlessly integrated while following international regulations of safety.
Research & Development - India has a large branded generics market which enables most companies to launch their version of a generic drug in the market place. Research and Development is an important aspect for development of generics that match the quality and cost targets.
